Mesenchymal stem cells from Wharton’s jelly
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal stem cells from Wharton’s jelly, covering 2021-11-05 to 2021-11-05. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome [Phase 2]